<DOC>
	<DOC>NCT02920944</DOC>
	<brief_summary>This study aims to examine technical feasibility and diagnostic yield of new 20-gauge Procore needle for EUS-guided fine needle biopsy in solid lesions by comparing with 22-gauge Procore needle. The study design is prospective, randomized study.</brief_summary>
	<brief_title>Diagnostic Yield of 20-gauge Procore Needle for EUS-guided FNA Biopsy in Solid Pancreatic Lesions</brief_title>
	<detailed_description />
	<mesh_term>Pancreatic Neoplasms</mesh_term>
	<criteria>Patients older than 20 years referred to our medical center for EUSFNB with diagnosed or suspected solid pancreatic masses according to clinical evaluation and imaging studies. cystic pancreatic lesions, patients haemodynamically unstable or with severe coagulopathy (international normalized ratio [INR] &gt; 1.5 or platelet count &lt; 50,000 cells/cubic millimeter [cmm3]), patients unable to suspend anticoagulant/antiplatelet therapy, pregnancy, inability or refusal to give informed consent, and refusal to participate in the study.</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>